University of Iowa
Also known as: Ahmed Mohamed Mahrous | Anjali Sharathkumar | Annah J. Vollstedt | Anna Stanhewicz, PhD | Archit Sharma | Arwa Owais | Assistant Professor, Department of Radiation Oncology, The University of Iowa | Assouline-Dayan, Yehudith | Bryan Allen | Carlos Chan | Clinic 17 - University of Iowa | Clinical Trials Statistical and Data Management Center, University of Iowa | College of Dentistry | David Bender | David Bushnell | David Hasan | Department of Dermatology, University of Iowa | Department of Radiation Oncology, The University of Iowa | Donna Hammond, PhD | Eric A. Hoffman | Erica Teixeira | Ericka Lawler | Gary L. Pierce | Gregory A. Schmidt | Guido Tricot | Gustavo Avila-Ortiz | Gustavo Avila-Ortiz DDS, MS, PhD | Holden Comprehensive Cancer Center | Institute of Quantitative Systems Pharmacology (IQSP) | Iowa University | Jennifer Hrabe | Jerrry L Lewis | J L Marsh | Jordan Schultz | Joseph Caster, Ph.D., M.D. | Joseph J. Cullen | Kanchna Ramchandran | Kathleen Sluka | Kevin J Flynn MD | Kyle Stein | Linnea Polgreen | Marin L. Schweizer, PhD | Mario Zanaty | Michael Graham | Michelle Weckmann | Mohammed M Milhem | Nathan Hendrickson | National Advanced Driving Simulator at the University of Iowa | National Advanced Driving Simulator, University of Iowa | Nazan Aksan | Nicholas Kruse | Nicholas M Mohr | Nicholas Salava | Nicole K Brogden | Nicole M. Masse | O'Dorisio, M S | Paolo Goffredo | Prof. Dr. Umar Farooq | Professor of Surgery, The University of Iowa | Punam Saha | Qiang Zhang | Rakesh Sondekoppam Vijayashankar | Richard JH Smith | Rohan Garje | Roy A. & Lucille A. Carver College of Medicine | Rup Sainju | Ruth Chimenti | Sandeep Laroia | Spyridon Fortis | Stacey Dejong | Sue O'Dorisio | Sundara Reddy | Terry L. Wahls | The Department of Radiation Oncology, The University of Iowa | The University of Iowa | The University of Iowa and the Iowa City VAMC | The University of Iowa Carver College of Medicine | The University of Iowa Hospitals & Clinics | The University of Iowa Psychiatry Department | Timothy L. Brown | UIHC | UIHC PET IMAGING | UIowa College of Dentistry | Umar Farooq | University of Iowa | University of Iowa Adolescent and Young Adult (AYA) Cancer Program | University of Iowa, Carver College of Medicine, Department of Internal Medicine | University of Iowa College of Dentistry | University of Iowa College of Dentistry and Dental Clinics | University of Iowa Department of Urology | University of Iowa Foundation | University of Iowa Health Care | University of Iowa Health Center | University of Iowa Holden Comprehensive Cancer Center | University of Iowa Hospital | University of Iowa Hospital and Clinics | University of Iowa Hospital and Clinics, Department of Ob/Gyn | University of Iowa Hospital & Clinics | University of Iowa Hospitals | University of Iowa Hospitals and Clinic | University of Iowa Hospitals and Clinics, Carver College of Medicine, and Holden Comprehensive Cancer Center,Iowa City, Iowa | University of Iowa Hospitals & Clinics | University of Iowa Hospitals & Clinics, Iowa City, IA | University of Iowa Hosptials & Clinics | University of Iowa Medical Center | University of Iowa Psychiatry Department | University of Iowa, Stead Family Children's Hospital | University of Iowa; Veteran Affairs | Univ of Iowa | Unyime Ituk | Varun Monga | Varun Monga, MD | Warren Bishop | Wei Chen | Weigel, Ronald | William Coryell | William Terry | Yehudith Assouline-Dayan | Yogesh Jethava | Yousef Zakharia | Yu-Hsiang Wu | Yusuf Menda
Highest phase reached
Phase 4
First clinical trial
Jun 1, 1973First marketed drug
Aug 6, 2014First NDA
Aug 21, 2019Last known activity
Sep 1, 2026
Timeline
1840s
- Jan 1, 1847
University of Iowa— Founded
2010s
- Nov 17, 2015
sodium fluoride (18F)— Marketing Organization
- Aug 21, 2019
ga-68-dota-toc— NDA Organization
Drugs by trial phase (312 distinct, 373 trials)
Phase 4 (75 own, 0 via acquisition)
Phase 3 (48 own, 0 via acquisition)
Phase 2 (112 own, 0 via acquisition)
Phase 1 (50 own, 0 via acquisition)
Other trials (27 own, 0 via acquisition)
Indications
Studied for
- Abdominal Abscess
- Acute Kidney Injury
- Adenocarcinoma
- Adenoma, Islet Cell
- Alzheimer Disease
- Amyloidosis
- Anemia
- Anemia, Aplastic
- Anemia, Iron-Deficiency
- Anemia, Neonatal
- Aneurysm
- Ankle Fractures
- Anxiety Disorders
- Atherosclerosis
- Atrial Fibrillation
- Autoimmune Diseases
- Behcet Syndrome
- Birth Weight
- Blindness
- Blood Coagulation Disorders
- Body Weight
- Borderline Personality Disorder
- Bradycardia
- Brain Neoplasms
- Breast Neoplasms
- Bronchopulmonary Dysplasia
- Calculi
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Adenoid Cystic
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Cardiovascular Diseases
- Carotid Body Tumor
- Cerebral Hemorrhage
- Cerebral Infarction
- Chest Pain
- Chondrosarcoma
- Chorea
- Cleft Lip
- Cleft Palate
- Cognition Disorders
- Cognitive Dysfunction
- Colonic Neoplasms
- Colorectal Neoplasms
- Communicable Diseases
- Conduct Disorder
- Congenital Abnormalities
- Conjunctivitis
- Conjunctivitis, Allergic
- Constipation
- Coronary Artery Disease
- Coronary Disease
- Cystic Fibrosis
- Cystitis
- Delirium
- Dementia
- Dental Caries
- Depression
- Depression, Postpartum
- Depressive Disorder
- Diabetes Mellitus, Type 1
- Disease
- Ductus Arteriosus, Patent
- Emergence Delirium
- Emergencies
- Emphysema
- Eosinophilic Esophagitis
- Esophagitis
- Esophagitis, Peptic
- Fabry Disease
- Femoral Fractures
- Fibrosis
- Fistula
- Fractures, Bone
- Fructose Intolerance
- Gambling
- Gastroesophageal Reflux
- Gastrointestinal Stromal Tumors
- Gastroparesis
- Glioblastoma
- Glomerulonephritis
- Glomerulonephritis, Membranoproliferative
- Glucose Intolerance
- Graft vs Host Disease
- Headache
- Head and Neck Neoplasms
- Heart Diseases
- Hemophilia A
- Hemorrhage
- Hemostatic Disorders
- Huntington Disease
- Hyperemia
- Hyperplasia
- Hypersensitivity
- Hypertension
Marketed drugs (3)
Recent trials (50)
- NCT07288450Sponsor investigatorPhase 1/Phase 2Sep 1, 2026
- NCT07288450Lead sponsorPhase 1/Phase 2Sep 1, 2026
- NCT07288450OfficialPhase 1/Phase 2Sep 1, 2026
- NCT07283900Sponsor investigatorPhase 2May 1, 2026
- NCT07283900OfficialPhase 2May 1, 2026
- NCT07283900Lead sponsorPhase 2May 1, 2026
- NCT07177079Sponsor investigatorPhase 1Dec 31, 2025
- NCT07177079Lead sponsorPhase 1Dec 31, 2025
- NCT07177079OfficialPhase 1Dec 31, 2025
- NCT07224269Lead sponsorEarly Phase 1Nov 17, 2025
- NCT07224269OfficialEarly Phase 1Nov 17, 2025
- NCT07224269Sponsor investigatorEarly Phase 1Nov 17, 2025
- NCT07244809Sponsor investigatorN/AOct 13, 2025
- NCT07244809Lead sponsorN/AOct 13, 2025
- NCT07185724Lead sponsorPhase 4Oct 1, 2025
Details
- Founded
- Iowa City, Iowa, US Jan 1, 1847
- First NDA
- Aug 21, 2019
- Last known activity
- Sep 1, 2026
Designations held
- Orphan drug